SLC38A3 and hepatocellular carcinoma: Conversely to SLC38A3, upregulation of SLC38A1, SLC7A6, and SLC1A5 transporters in HCC tumors was associated with decreased overall patient survival, with SLC1A5 being the most significantly associated with tumor aggressiveness.